On 03apr2017 an eye care provider (ecp) called our affiliate in the (b)(6) to report that the patient (pt) ¿had a serious eye infection on his/her eyes¿ while wearing the 1-day acuvue trueye brand contact lenses.
It was reported that the ecp is the pts parent.
The ecp reported that the pt called approximately three weeks ago and complained of a ¿white spot on his/her eye, but reported no pain or other symptom.
¿ the ecp advised the pt to go to an ophthalmologist, who gave eye drops.
The pts eye felt gritty after eye drops were put in and reported that the pts ¿eye turned pink.
¿ the pt is still using eye drop today.
On 10apr2017 a return call was placed to the ecp (pts parent) in the (b)(6) by a johnson and johnson professional affairs physician and the additional information was provided: the right eye is the affected eye; two lesions approximately 0.
8 mm in size at 11 o¿clock; no anterior chamber reaction; symptoms: photophobia and redness, initially mild but escalating to significant over two hours; va prior to event 6/6; current va not known (review appointment scheduled (b)(6) 2017; ophthalmology report: 1.
Contact lens related keratitis; paraxial superior sub-epithelial corneal fibrosis; myopic astigmatism; corneal micropannus.
Treatment: ofloxacin initially every hour, chloramphenicol 1% bes; prednisolone 0.
5 % preservative free for two weeks; treatment suggests this was a moderate case of bacterial keratitis.
On 17apr2017 an email was received from the affiliate in the (b)(6) that no corneal scrapes were taken.
The event date is reported as (b)(6) 2017.
A follow-up appointment is scheduled for (b)(6) 2017.
The pt is still receiving ongoing treatment with prednisolone drops.
Additional medical information was requested.
The product was requested for return, but it has not yet been received.
A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing.
All parameters tested were within specification.
All sterilization requirements were successfully completed.
Lot 5512010110 was produced under normal conditions.
If additional information is received it will be reported within 30 days of receipt.
Serious reportable event trends are reviewed quarterly in franchise management review meetings.
|